शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
MAXHEALTHNSEMAX HEALTHCARE INS LTD· Healthcare ServicesHighNegative
Announced Fri, 24 Jul, 2026 · 12:10 IST

NCLT adjourns Kalinga Hospital petition hearing to August 4

MAXHEALTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.0%Reaction day
₹1080.00
prior close
₹1078.00
announcement price
In-mkt
timing
Nifty 100market-0.4%+0.4% vs market
Hospital peers, median of 24sector-0.2%+0.2% vs sector

On the reaction day the stock moved 0.4 pts more than Nifty 100 and 0.2 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
-0.0
30m
+0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.0-0.4+0.4-0.2+0.2
Next day
+3.5+0.6+2.8+0.7+2.7
2d
+2.2+0.5+1.7+0.2+2.0
3d
+3.0+1.5+1.5+0.4+2.5
4d
+4.1+1.7+2.3+0.4+3.7
5d
+1.9+2.2-0.3-0.1+2.0
1w
-0.3+3.2-3.4+0.5-0.7
15d
-6.6+2.4-9.0+0.1-6.7
1m
-8.3+1.8-10.0-1.1-7.2
2m
-3.1-2.9-0.3+0.6-3.7
3m
-22.3-5.2-17.1-14.9-7.5
UpDownMarket · Nifty 100Sector · Hospital peers, median of 24Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Max Healthcare has updated the stock exchanges on an ongoing NCLT Cuttack Bench case. Petitions were filed by legal representatives of BRS Capital Two Pte. Limited against subsidiary Kalinga Hospital Ltd, the other shareholder from whom Max acquired a majority stake, and the Company itself. The NCLT has adjourned the matter to August 4, 2026 for further hearing. No settlement has been reached, and the disclosure does not apply to key management personnel. This is a continuation of earlier intimations dated May 19 and July 8, 2026.

Likely market impact

Matter remains pending with no settlement or financial impact disclosed. Next hearing on August 4, 2026 may bring further clarity for shareholders.